Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Direct immunofluorescence is of limited utility in patients with low clinical suspicion for an oral autoimmune bullous disorder.

Bresler SC, Bavarian R, Granter SR, Woo SB.

Oral Dis. 2019 Jul 19. doi: 10.1111/odi.13159. [Epub ahead of print]

PMID:
31323154
2.

Altered Rb, p16, and p53 expression is specific for porocarcinoma relative to poroma.

Zahn J, Chan MP, Wang G, Patel RM, Andea AA, Bresler SC, Harms PW.

J Cutan Pathol. 2019 Sep;46(9):659-664. doi: 10.1111/cup.13480. Epub 2019 May 3.

PMID:
31012122
3.

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

Rabinowits G, Lezcano C, Catalano PJ, McHugh P, Becker H, Reilly MM, Huang J, Tyagi A, Thakuria M, Bresler SC, Sholl LM, Shapiro GI, Haddad R, DeCaprio JA.

Oncologist. 2018 Jul;23(7):814-821. doi: 10.1634/theoncologist.2017-0552. Epub 2018 Feb 14.

4.

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma.

Merryman RW, Kim HT, Zinzani PL, Carlo-Stella C, Ansell SM, Perales MA, Avigdor A, Halwani AS, Houot R, Marchand T, Dhedin N, Lescaut W, Thiebaut-Bertrand A, François S, Stamatoullas-Bastard A, Rohrlich PS, Labussière Wallet H, Castagna L, Santoro A, Bachanova V, Bresler SC, Srivastava A, Kim H, Pesek E, Chammas M, Reynolds C, Ho VT, Antin JH, Ritz J, Soiffer RJ, Armand P.

Blood. 2017 Mar 9;129(10):1380-1388. doi: 10.1182/blood-2016-09-738385. Epub 2017 Jan 10.

5.

5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms.

Lee JJ, Vilain RE, Granter SR, Hu NR, Bresler SC, Xu S, Frank AH, Mihm MC Jr, Saw RP, Fletcher CD, Scolyer RA, Murphy GF, Lian CG.

J Cutan Pathol. 2017 Mar;44(3):249-255. doi: 10.1111/cup.12880. Epub 2017 Feb 6.

PMID:
28032662
6.

Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity.

Bresler SC, Min L, Rodig SJ, Walls AC, Xu S, Geng S, Hodi FS, Murphy GF, Lian CG.

Lab Invest. 2017 Feb;97(2):207-216. doi: 10.1038/labinvest.2016.126. Epub 2016 Dec 5.

7.

Factoring in the missing link.

Sethi N, Sedighi Manesh R, Sperling A, Bresler SC, Connell NT, Tierney LM.

Am J Hematol. 2017 Jan;92(1):110-113. doi: 10.1002/ajh.24501. Epub 2016 Aug 22. No abstract available.

8.

Politics, culture, and the legitimacy of disease: the case of Buerger's disease.

Lockwood SJ, Bresler SC, Granter SR.

Clin Rheumatol. 2016 Sep;35(9):2145-9. doi: 10.1007/s10067-016-3310-1. Epub 2016 May 18. Review.

PMID:
27188859
9.

Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome).

Bresler SC, Padwa BL, Granter SR.

Head Neck Pathol. 2016 Jun;10(2):119-24. doi: 10.1007/s12105-016-0706-9. Epub 2016 Mar 14. Review.

10.

Utility of direct immunofluorescence testing for IgA in patients with high and low clinical suspicion for dermatitis herpetiformis.

Bresler SC, Granter SR.

Am J Clin Pathol. 2015 Dec;144(6):880-4. doi: 10.1309/AJCPXIVSR6OZK1HU.

PMID:
26572994
11.

Malignant tenosynovial giant cell tumor of the leg: a radiologic-pathologic correlation and review of the literature.

Richman DM, Bresler SC, Rosenthal MH, Howard SA.

J Clin Imaging Sci. 2015 Feb 27;5:13. doi: 10.4103/2156-7514.152343. eCollection 2015.

12.

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.

Bresler SC, Weiser DA, Huwe PJ, Park JH, Krytska K, Ryles H, Laudenslager M, Rappaport EF, Wood AC, McGrady PW, Hogarty MD, London WB, Radhakrishnan R, Lemmon MA, Mossé YP.

Cancer Cell. 2014 Nov 10;26(5):682-94. doi: 10.1016/j.ccell.2014.09.019. Epub 2014 Nov 10.

13.

Giant cell tumor of soft tissue.

Bresler SC, Wanat KA, Elenitsas R.

Cutis. 2014 Jun;93(6):278;286-8. No abstract available.

PMID:
24999647
14.

Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma.

Carpenter EL, Haglund EA, Mace EM, Deng D, Martinez D, Wood AC, Chow AK, Weiser DA, Belcastro LT, Winter C, Bresler SC, Vigny M, Mazot P, Asgharzadeh S, Seeger RC, Zhao H, Guo R, Christensen JG, Orange JS, Pawel BR, Lemmon MA, Mossé YP.

Oncogene. 2012 Nov 15;31(46):4859-67. doi: 10.1038/onc.2011.647. Epub 2012 Jan 23. Erratum in: Oncogene. 2012 Nov 15;31(46):4888. Vigny, M [added]; Mazot, P [added].

15.

Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma.

Bresler SC, Wood AC, Haglund EA, Courtright J, Belcastro LT, Plegaria JS, Cole K, Toporovskaya Y, Zhao H, Carpenter EL, Christensen JG, Maris JM, Lemmon MA, Mossé YP.

Sci Transl Med. 2011 Nov 9;3(108):108ra114. doi: 10.1126/scitranslmed.3002950.

Supplemental Content

Loading ...
Support Center